These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5856999)

  • 1. Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal.
    Takeo Y; Himwich HE
    Science; 1965 Dec; 150(3701):1309-10. PubMed ID: 5856999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative electroencephalographic study of phenylethylamines and their methoxy derivatives.
    Takeo Y; Himwich HE
    Arch Int Pharmacodyn Ther; 1967 Mar; 166(1):47-59. PubMed ID: 6034328
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies on mescaline: the effect of dimethoxyphenylethylamine and N:N-dimethyl mescaline on the conditioned avoidance response in the rat.
    Smythies JR; Sykes EA
    Psychopharmacologia; 1966; 8(5):324-30. PubMed ID: 5923938
    [No Abstract]   [Full Text] [Related]  

  • 5. A new view of the structural relationship between LSD and mescaline.
    Nichols DE; Pfister WR; Yim GK; Cosgrove RJ
    Brain Res Bull; 1977; 2(3):169-71. PubMed ID: 890502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response.
    Bridger WH; Mandel IJ
    Life Sci; 1967 Apr; 6(7):775-81. PubMed ID: 6031262
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of a low dosage of mescaline and 3,4-dimethoxyphenylethylamine under two levels of aversive stimulation.
    Levis DJ; Caldwell DF
    Biol Psychiatry; 1971; 3(3):251-7. PubMed ID: 5163810
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of tolerance to the antinociceptive effect of mescaline intraventricularly administered to rabbits.
    Ferri S; Santagostino A; Braga PC
    Psychopharmacology (Berl); 1976 Jun; 47(3):261-5. PubMed ID: 823561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline.
    Smythies JR; Johnston VS; Bradley RJ
    Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of activating systems on neocortical after-discharges.
    Kreindler A; Crighel E; Steriade M
    Prog Brain Res; 1968; 22():286-96. PubMed ID: 5651171
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 3,4-dimethoxyphenylethylamine in man.
    Hollister LE; Friedhoff AJ
    Nature; 1966 Jun; 210(5043):1377-8. PubMed ID: 5963772
    [No Abstract]   [Full Text] [Related]  

  • 13. Electroencephalographic alerting sites of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine.
    Fujimori M; Himwich HE
    Nature; 1968 Nov; 220(5166):491-4. PubMed ID: 5686169
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychoactivity of normacromerine in animals.
    Bourn WM; Keller WJ; Bonfiglio JF
    Life Sci; 1978 Sep; 23(11):1175-84. PubMed ID: 713693
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-unit activity in cat's isolated midbrain.
    Zernicki B; Dec K; Sarna M; Jastreboff P; Verderevskaya N
    Acta Neurobiol Exp (Wars); 1979; 39(5):345-52. PubMed ID: 539478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mescaline and 2,5-dimethoxy-4-methylphenethylamine on sleeping time in mice.
    Ho BT; Huang JT
    J Pharm Pharmacol; 1970 Dec; 22(12):949-51. PubMed ID: 4395524
    [No Abstract]   [Full Text] [Related]  

  • 17. The central effects of the beta-adrenergic blocking agent INPEA.
    Ilyutchenok RYu ; Gilinsky MA; Yeliseyeva AG; Jivotikoff BP; Loskutova LV; Pastoukhoff YuF
    Neuropharmacology; 1972 Sep; 11(5):609-14. PubMed ID: 4151248
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of mescaline, amphetamine and four-ring substituted amphetamine derivatives on spontaneous brain electrical activity in the cat.
    Fairchild MD; Alles GA; Jenden DJ; Mickey MR
    Int J Neuropharmacol; 1967 May; 6(3):151-67. PubMed ID: 6037524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the electrocortical effects of acetylcholine and adrenaline in experimental hyperthyreosis in rabbits].
    Faĭfura VV
    Probl Endokrinol Gormonoter; 1966; 12(6):103-5. PubMed ID: 6004045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.